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Mononuclear phagocytes are known to be long-lived cells, capable of synthesis 
of new cellular constituents and of major alterations in metabolic activities and 
morphology (1).  In contrast, the neutrophil generally has been considered an 
end-stage cell, incapable of significant functional or metabolic modulation. How- 
ever, Granelli-Piperno et ai. (2, 3) have reported that human neutrophils actively 
synthesize protein and RNA and secrete plasminogen activator when placed in 
culture, and that these activities can be stimulated by incubation of the cells with 
concanavalin A and inhibited by incubation with glucocorticoids. These findings, 
and the capacity of small amounts of bacterial endotoxin (lipopolysaccharide, 
LPS)  ~ to  prime  mononuclear phagocytes for  enhanced  stimulated release  of 
superoxide anion (O~) (4,  5), suggested to us that neutrophil function might be 
modified by exposure to LPS. We report here that incubation of human neutro- 
phils for 30-60 min with LPS primes these cells for enhanced release of O~ or 
hydrogen peroxide (H~O~) upon subsequent contact with a  variety of stimuli. 
This increase in oxidative metabolism might permit increased effectiveness of 
the  neutrophil  in  host  defense.  These  results  also  raise  the  possibility  that 
exposure of neutrophils to bacterial  LPS could enhance the capacity of these 
cells to damage tissue, which might occur in conditions such as endotoxic shock 
or infection-induced adult respiratory distress syndrome. 
Materials and Methods 
Preparation of Neutrophils.  Human neutrophils were isolated from venous blood anti- 
coagulated  with  10%  sodium  citrate  (3.8% solution  in  water;  Fisher  Scientific Co., 
Pittsburgh,  PA). 3 vol blood were added to 1 vol 6% dextran (70,000 tool we) in 0.9% 
sodium chloride  solution (Cutter Laboratories,  Berkeley, CA) and allowed to stand at 
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room temperature for 1 h. The leukocyte-rich plasma was aspirated and centrifuged, and 
the erythrocytes were removed by hypotonic lysis (6).  The cells were washed twice and 
resuspended in Krebs-Ringer phosphate buffer, pH 7.23,  with 0.2%  dextrose (KRPD), 
prepared  with  dextrose  in  0.9%  NaCI  solution  (Cutter  Laboratories).  The  final  cell 
preparation contained 80-89% neutrophils. Neutrophiis, made >99% pure by the use of 
FicolI-Hypaque gradients (6) containing large amounts of LPS or of plasma and Percoll 
(Sigma Chemical Co., St. Louis, MO) by a modification of a method previously described 
(7),  were capable of being fully primed by incubation  with  LPS.  Values obtained with 
control cells (no incubation  with  LPS),  however, were elevated compared with  results 
achieved with cells obtained by dextran sedimentation. 
All reagents (in concentrated stock solutions) and plastic ware used in the preparation 
of cells and in assays were tested for LPS contamination by the limulus amebocyte lysate 
assay (Sigma Chemical Co.) (4) and were determined to be free of detectable LPS. (The 
limulus assay was capable of detecting 0.1  ng/ml of reagent LPS.) Plastics were tested by 
placing the limulus solution directly into the plastic ware, incubating at 37 °C for 1 h, and 
examining for gelation of the solution. 
Priming of Neutrophils with LPS.  Cells were incubated at 37°C for varying periods of 
time with KRPD containing LPS extracted with phenol from Escherichia coli K235 (4, 5, 
8) (a gift from Dr. Floyd Mclntire,  University of Colorado School of Dentistry) or with 
KRPD alone. This LPS was free of lipid A-associated endotoxic protein and contained 
no detectable ubiquinone (4, 8). LPS from E. eoli 011 l:B4, 026:B6, 0127:B8, and 055:B5 
(List  Biological  Laboratories,  Campbell, CA), E.  eoli 0128:B12  (Sigma Chemical  Co.), 
Salmonella  minnesota  Re  595  (List Biological  Laboratories), and S.  abortus equii (Difco 
Laboratories, Detroit, MI), and lipid A from S. minnesota Re 595 (List Biological Labo- 
ratories) also were found to prime neutrophiis for enhanced OF release (60-min pretreat- 
ment with 10-100 ng/ml LPS at 37 ° C); however, most of the experiments reported here 
used LPS from E. coli K235. At the end of the pretreatment time, cells were determined 
to be >98% viable by the exclusion of trypan blue. Neutrophil clumping did not occur, 
as determined by microscopy of cells in suspension. Stimuli for OF or H~O2 release were 
added without removal of the LPS; in seven paired experiments, the effect of LPS on OF 
release  was  almost  identical  in  preparations  in  which  the  LPS-containing  buffer  was 
removed after  10-60 min of preincubation and the cells were washed and again prein- 
cubated at 37°C for a total of 60 min before addition of the stimulus. 
Preparation of Stimuli.  Complexes of bovine serum albumin (BSA)  (Sigma Chemical 
Co.)  and  antibody  to  BSA  raised  in  rabbits  were  formed  at  equivalence  at  4°C  in 
phosphate-buffered saline, pH 7.4 (PBS) and adhered to micropore filters (25 mm diam, 
5 #m pore size;  Millipore Corp., Bedford, MA). Filters were washed five times with PBS 
before addition of cells (9). 
Phorbol  myristate acetate  (PMA)  was  obtained  from  Consolidated  Midland  Corp., 
Brewster,  NY  and  diluted  in  dimethylsulfoxide  (grade  I;  Sigma  Chemical  Co.)  to  a 
concentration of 450 ng/ml. Formyl-methionyl-leucyl-phenylalanine (FMLP) was obtained 
from Vega Biochemicals, Tucson, AZ and diluted in saline to a stock concentration of 0.1 
mM. 
Release of OF by Neutrophils.  Release of OF was determined in duplicate or triplicate 
reaction  mixtures,  as previously described  (6,  9),  by superoxide dismutase-inhibitable 
reduction  of cytochrome c (type III; Sigma Chemical Co.).  Micropore filters to which 
preformed immune complexes had  been  fixed were placed in  individual  35-mm diam 
tissue  culture  dishes  (Falcon  Labware,  Oxnard,  CA).  A  mixture of cytochrome c and 
KRPD, with or without superoxide dismutase (Diagnostic Data Inc., Berkeley, CA), was 
added to each dish; and 4  ×  106 cells that had been pretreated with LPS or with KRPD 
alone were added to start the reaction. The mixtures were incubated at 37 °C for 60 min, 
then aspirated and iced immediately. Cells were removed by centrifugation and the A550 
of the supernatant was determined. 
In assays using PMA (1.5 ng/mi to  1 #g/ml) or FMLP (1  #M) as the stimulus, OF was 
measured in  a  similar manner,  except that the cells were gently agitated at  37°C  in a 
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was  10  min  and  2.5  x  106 neutrophils  were  used.  In both assay systems,  the  reaction 
volume was 1.5 ml, the cytochrome c concentration was 0.08 mM, and the concentration 
of superoxide dismutase, when present, was 50 #g/ml. 
Release of O~ was measured continuously in a Cary 219 double-beam spectrophotom- 
eter  fitted  with  heated  (37°C) and stirred  cuvettes and a  recorder.  Neutrophils  (2.5  X 
106), preincubated with LPS, 10 ng/ml, or buffer were added to paired cuvettes containing 
0.08  mM  cytochrome  c  in  KRPD;  the  reference  cuvette also  contained  superoxide 
dismutase,  50 ~g/ml.  The assay volume was 3 ml. After stabilization of the tracing (1-2 
rain),  1/~M FMLP was added as stimulus. Assays were performed in duplicate or triplicate. 
Release  of H'202 and  Consumption  of Oxygen by  Neutrophils.  Release  of  H~O2  was 
measured by quantitating peroxidase-mediated oxidation of scopoletin by H202 using a 
modification of a previously described technique (9,  10).  Horseradish peroxidase, scopo- 
letin (10), and 5 x  106 granulocytes were present in the 3-ml reaction mixture, which was 
not stirred.  The decrease in  fluorescence of scopoletin was measured  continuously in a 
recording spectrofluorometer at 37°C after addition of 1 ttM  FMLP as stimulus.  Assays 
were performed in duplicate and results are reported as initial (maximal) rates. 
Consumption  of oxygen  by  neutrophils  was  measured  continuously  at  37°C  by  a 
polarographic technique using a Clark membrane electrode (Yellow Springs Instrument 
Co., Yellow Springs, OH). Neutrophils were preincubated with  10 ng/ml LPS or buffer 
alone at  37°C for 60 min.  The 3-ml assay volume contained  2.5-20  x  106 neutrophils 
and 2 mM  KCN in  KRPD. After stabilization of the tracing,  1 ~M  FMLP was added to 
start the reaction. Results varied directly with cell number within the range studied (2.5- 
20 x  10~). Assays were performed in duplicate or triplicate. Results are expressed as initial 
(maximal) rates. 
Effect of Cycloheximide on Priming of Neutrophils by LPS.  Cycloheximide (Sigma Chemical 
Co.),  1-50 ug/ml, was preincubated with neutrophils at 37°C for 15 min before addition 
of the LPS for the 60-min preincubation. That cycloheximide inhibited neutrophil protein 
synthesis  in  this  system  was  demonstrated  by  studying  incorporation  of [14C]leucine. 
Neutrophils were resuspended in medium  199 without amino acids (Gibco Laboratories, 
Grand  Island,  NY)  at  1  x  107/ml.  [14C]Leucine (0.5  uCi/ml)  (New  England  Nuclear, 
Boston, MA) was added with or without cycloheximide, with or without  10 nM  FMLP. 
Cells and supernatant were harvested at 2 or 24 h and precipitated with an equal volume 
of cold 20% trichloracetic acid (TCA) in the presence of added albumin as a carrier. The 
precipitate  was  washed and  counted  for  incorporated  radioactivity.  FMLP  stimulated 
incorporation of [~4C]leucine into TCA-precipitable  material by approximately twofold. 
Cycloheximide  (10  /~g/ml)  inhibited  the  incorporation  by  >90%  in  both  resting  and 
stimulated conditions, at both 2 and 24 h. Cellular integrity, checked by examination of 
the release of lactate dehydrogenase (9) in parallel tubes, was equivalent in the presence 
or absence of cycloheximide. 
Binding  of FMLP  to  Neutrophils.  FMLP  binding  to  neutrophils  was  studied  by  a 
modification  of the  technique  described  for rabbit  neutrophils  by  Mackin  et  al.  (11). 
Neutrophils at  1 x  107/ml were preincubated in buffer or buffer with LPS, 10 ng/ml, for 
60 min at 37°C. 250 ~tl of this cell suspension was layered onto silicone fluid with an equal 
volume of F-met-leu-3H phe (New England Nuclear).  The tubes were incubated at 4°C 
for 30 min, and then  the cells were separated  from unbound peptide by centrifugation 
for  30  s in  a  microcentrifuge.  The pellets  were solubilized  and  counted.  Binding data 
were analyzed with  the  LIGAND program (11). Analysis of the Scatchard plots did not 
reveal  evidence for two populations of binding sites  on  these  cells,  consistent  with  the 
report of Koo et al.  (12)  for intact  human  neutrophils.  Because of the  concerns about 
Scatchard analysis raised  by Munson and  Rodbard (13),  we examined  a  wide range  of 
FMLP concentrations in these studies (2.7-32.4 pmol per tube). 
Release of OCe by Particulate Fractions  of Neutrophils.  Release  of O~ was measured  in 
particulate  fractions  prepared  from neutrophils  pretreated  with  10  ng/ml  LPS  for 60 
rain, and  from control neutrophils,  using a  modification of a  previously described tech- 
nique (14).  After preincubation with LPS, the cells were treated for 3 min at  37°C with 
I ug/ml  PMA, disrupted  by sonication, and centrifuged,  first at  500 g, then at 9,500 g. GUTHR1E  ET  AL.  1659 
The supernate  was centrifuged again to yield a  40,000 g pellet containing the activated 
enzyme. ~75% of the NADPH-dependent O72-producing activity of the crude cell sonicate 
is present in this pellet (15). The pellet was suspended in 0.34 M sucrose and assayed for 
superoxide dismutase-inhibitable  NADPH-dependent reduction of cytochrome c, as pre- 
viously described (14), except that sodium deoxycholate (Sigma Chemical Co.), 0.042%, 
was present in the reaction mixture (16). The total amount of protein in the pellet (14) 
and the activity of the plasma membrane marker alkaline phosphatase (10) were almost 
identical  in  particulate  fractions  made  from  PMA-stimulated  neutrophils  preincubated 
with  LPS or with  buffer.  In one of the experiments  plotted in  Fig.  3,  using an optimal 
concentration  of NADPH  (0.19  mM)  the  enhancement  in  O,~-producing activity after 
pretreatment of the cells with LPS (compared with buffer control) was equivalent in the 
crude cell sonicate and  in  the  final  particulate  fraction,  indicating that recovery of the 
oxidase was not affected by exposure of the cells to LPS. 
Results 
LPS-induced Priming for Enhanced Release of 02 
Human  neutrophils exposed to small amounts of LPS in vitro could be primed 
so that they released  increased amounts of OF in response to a variety of stimuli. 
As  summarized  in  Table  I,  neutrophils  pretreated  for  60  rain  with  10  ng/ml 
LPS,  when  allowed  to  contact  surface-bound  immune  complexes  or  when  ex- 
posed to the soluble stimuli  PMA or FMLP, released  ~50%  more to almost eight 
times  more  OF  than  did  the  same  preparation  of  neutrophils  preincubated 
without LPS. In itself,  LPS was not a stimulus for OF release, whether OF release 
was assayed from the time of the addition of LPS or after a  60-min pretreatment 
period with  LPS (Table  I). 
Neutrophils  were capable of being primed  by a  wide  range of concentrations 
TABLE  I 
Effect of Preincubation of Neutrophils with LPS on the Release of OF 
During Stimulation * 
Stimulus 
Release of O~  -~; 
(nmol/2.5 x  106 
neutrophils) 
Neutrophils  preincubated with: 
Buffer  LPS 
None (16)  8  2.0 +-- 0.2  2.1 -  0.1 
PMA, 1.5 ng/ml (12)  49.0-+5.2  80.6-+4.8 
Fixed immune complexes (21)  12.4 +  1.6  26.8 +  1.6 
FMLP, 1 ttM (35)  5.0 -+ 0.4  38.8 -+ 2.2 
* Cells were preincubated for 60 min with buffer (KRPD) or with KRPD 
containing LPS, 10 ng/ml. Stimulation  with immune complexes was for 
60 min and with PMA or FMLP for 10 min. Incubation in the absence 
of a stimulus was for 10 min, in suspension. 
* Mean _+ SEM. The number of paired experiments,  performed in dupli- 
cate or triplicate,  is given in parentheses  by the stimulus.  LPS-treated 
cells released  significantly more O~ with each of the three stimuli (P < 
0.001,  paired t tests). 
§ Addition of LPS (10  ng/ml) at the beginning of the incubation  with 
cytochrome c, and preincubation of neutrophils in LPS at concentrations 
of 1 gg/ml rather than  10 ng/ml gave results almost identical to those 
shown here (three experiments each). 1660  PRIMING  OF  NEUTROPHILS  BY  LIPOPOLYSACCHARIDE 
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FIGURE  1.  Release of OF by neutrophils preincubated with varying concentrations of LPS. 
The extent of O'~ release is plotted as a  function of the concentration of LPS used in the 
preincubation with neutrophils for 60 min. The release of O~ was stimulated by subsequent 
exposure of the cells for 60 min to immune complexes fixed to micropore filters or for  10 
min to FMLP,  1 uM. The results represent the means 4- SEM of three paired experiments 
with each stimulus. 
of LPS, as shown in Fig.  1, in which fixed immune complexes and FMLP were 
used as stimuli. The priming effect of LPS was variable from donor to donor. 
An effect at 0.1  ng/ml LPS was observed with cells from only some donors, but 
priming was consistently and clearly demonstrable at 1 ng/ml and optimal by 10 
or 100  ng/ml. Almost identical results for the effect of LPS concentration were 
obtained in two experiments using 1.5 ng/ml PMA as stimulus (data not shown). 
The effect of the duration of preincubation of neutrophils with LPS on the 
extent of OF release is shown in Fig. 2, using FMLP as stimulus. No significant 
effect was noted after 15 min of LPS pretreatment, whether FMLP (Fig. 2) or 
PMA or fixed complexes (not shown) were used subsequently as the stimulus. A GUTHRIE  ET  AL.  1661 
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FIGURE 2.  Release of O~ by neutrophils preincubated for varying lengths of time with LPS, 
10  ng/ml, or  with buffer alone  (control).  The  release  of O~ was stimulated by subsequent 
exposure  of the cells to FMLP,  1 #M,  for  10 min. Results represent  means _+ SEM of three 
paired experiments. 
small effect was consistently noted by 30 min, and the effect was prominent by 
45  min, whatever the stimulus used. By 60 min of preincubation, priming was 
~80% maximal with FMLP (Fig. 2) and 90-100%  maximal with PMA or fixed 
immune complexes (data not shown). The incubation of cells in buffer at 37°C 
did not alter their OF-releasing capacity: freshly prepared cells and cells incubated 
at 37°C for 60 min released an equivalent amount of OF (29.2 _.+  1.8 and 28.6 
_+ 3.0 nmol, respectively; n =  3, using immune complexes as stimulus). 
Although preincubation at 37 °C after exposure of cells to LPS was required 
for priming, the effect could be achieved if the cells were exposed to the LPS at 
37°C for as short as  1 min, then centrifuged after 45 s additional time, washed 
once,  and  resuspended  in  a  fresh  tube  in  LPS-free  buffer  for  the  60-min 
preincubation period (mean enhancement 5.2-fold with standard procedure, 4.1- 
fold with brief exposure; n  =  2;  10 ng/ml LPS or FMLP as stimulus). Removal 
of the LPS and washing would dilute the LPS in the buffer to a concentration 
below that necessary for priming. Thus, effective association of the LPS with the 
cells must have taken place during the brief exposure. 
Neutrophils pretreated with LPS not only released increased amounts of OF 
but the release began more quickly and occurred at a faster rate. As shown in 
Table  II, when OF release was monitored continuously, the lag time between 
addition of the stimulus and appearance of  detectable release of OF was decreased 
markedly after preincubation of the neutrophils in LPS, and the rate of release 
was faster. The duration of OF release was equivalent for the two cell types using 
1 #M FMLP as stimulus (2.8 _  0.2 min for LPS-treated cells,  2.4 +  0.2 min for 
control; mean ___ SEM, n =  6, determined as the time until rate increase became 
negligible). Similar results to those in Table II were obtained in three experiments 
using fixed immune complexes as stimulus and OF measurement at 5, 7,  10,  15, 1662  PRIMING  OF  NEUTROPHILS  BY  LIPOPOLYSACCHARIDE 
TABLE  II 
Effect of  Priming by LPS on Lag Time and Rate of Release of O'~ * 
Stimulus 
Lag time  Rate 
Buffer  LPS  Buffer  LPS 
s  nmol/min 
FMLP,  1 #M  --*  8 +  1  3.2 _+ 0.8  19.3 +  1.7 
PMA, 1.5 ng/ml  67 +  12  13 +  3  13.0 +  2.0  21.4 4- 3.6 
PMA, 0.5 #g/ml  47 _  7  18 +  2  17.1  +  2.1  21.4 _  3.7 
PMA, 1 #g/ml  50 +  6  15 _+ 3  12.6 4-_ 0.6  21.0 _  3.7 
* Neutrophils  (2.5  x  106) were  preincubated  for  60  min  in  buffer  or 
buffer plus LPS, 10 ng/ml, then transferred to a cuvette for continuous 
spectrophotometric monitoring of O~ release. The time elapsed between 
addition of the stimulus and initiation of superoxide dismutase-inhibit- 
able reduction of cytochrome c (lag time), and the initial (maximal) rate 
of cytochrome reduction, were obtained from tracings. Results represent 
mean + SEM for three or four paired experiments with each stimulus. 
Activity was too low to permit accurate determination  of lag time, but 
values were estimated to be 12-20 s. 
20,  30,  and  60  min.  Detectable  release of O2 began  within  the  first  5  min for 
LPS-treated cells (6.8 4-  1.6 nmol; mean +  SEM); no release was detectable from 
control  cells after  incubation  for  7  min,  and  release  at  10  min  was  2.3  4-  0.7 
mnol.  The  maximal  rates  of release,  noted  between  0  and  15  min  with  LPS- 
treated  cells and  between  10  and  20  min  with  control  cells,  were  1.5  and  1.1 
nmol/min, respectively. 
Effect of LPS on Release of H202 and Consumption of Oxygen 
The priming effect of LPS was not confined to release of 02.  During stimula- 
tion  with  FMLP,  neutrophiis  preincubated  with  LPS,  10  ng/ml  for  60  min, 
released  H202  at a  rate of 7.1  4- 0.5  nmol/min per 5  x  106  cells (mean _  SEM, 
n  =  10) compared with a  rate of 2.0 +  0.5  nmol/min for buffer-pretreated cells 
(P <  0.001,  paired  t test).  The duration  of H202  release was equivalent  in the 
two cell types (relatively rapid release for about 2.5  min, further slight increase 
for up  to  ~5  min).  Release  of H202  by unstimulated  LPS-pretreated  cells was 
0.34  _+  0.05  nmol/min  and,  by unstimulated  control  cells,  0.36  +  0.01  nmol/ 
min (n =  4). 
The rate of FMLP-stimulated oxygen consumption by neutrophils pretreated 
with  LPS was also increased compared with that of control cells (8.1  +  0.5 and 
4.1  _+ 0.4 nmol/min per 2.5  x  106  cells, respectively; mean +  SEM,  n  =  5; P  < 
0.001).  The  duration  of oxygen  consumption  was  equivalent  for  the  two  cell 
types (2.8  +  0.1  min for LPS-treated cells,  2.6 ___ 0.1  min for control; time until 
rate  increase  became  negligible).  The  extent  of enhancement  in  the  rate  of 
oxygen uptake by LPS (1.9-fold) was less than the extent of enhancement of 02 
release (3.2-fold) in three paired experiments run simultaneously with the same 
cell preparations. 
Investigation of the Molecular Basis of Priming 
Effect of temperature, cycloheximide, calcium ion, and serum.  The priming event 
was tentperature-dependent.  There  was no  effect if cells were pretreated  with GUTHRIE  ET  AL.  1663 
TABLE  III 
Effect of Temperature or Cycloheximide  on Priming by LPS* 
Release of O~  "* 
Preincubation  LPS  Cycloheximide  (nmol/2.5 ×  10  6 
temperature  neutrophils) 
0°C  -  -  6.5 _+ 1.7 (3) 
0°C  +  -  6.4_+ 1.8 (3) 
37°C  +  -  39.2 + 9.3 (3) 
37°C  -  -  7.1 +  0.9 (4) 
37°C  +  -  41.8 _  2.6 (4) 
37°C  +  10 t~g/ml  37.0 +  4.1  (4) 
* Neutrophils were preincubated at 0°C or 37°C in buffer or buffer plus 
LPS,  10 ng/ml, for 60 rain before addition of the assay mixture for O~-, 
which included FMLP, 1 t~M, as stimulus. Cycloheximide, when present, 
was preincubated with neutrophils at 37°C for  15 min before addition 
of the LPS. 
Mean +  SEM; the number of experiments is given in parentheses. 
LPS at 0°C for 60 min, as shown in Table III, using FMLP as stimulus. Results 
were similar in two experiments with PMA as stimulus. The presence of cyclo- 
heximide at concentrations of 1, 5,  10,  20, or 50 #g per ml  15 min before and 
during the 60-min preincubation with LPS did not prevent the priming by LPS. 
Results with 10 #g/ml are shown in Table III. Cycloheximide at this concentra- 
tion inhibited cellular incorporation of [~4C]leucine by >90% (see Materials and 
Methods). 
Priming did not require the presence of calcium ion (Ca  ++) in the extracellular 
medium, although absence of Ca  ++ during a  60  min preincubation did reduce 
the extent of O~ release.  Neutrophils pretreated for 60 min in buffer without 
Ca  ++ or Mg  +÷, containing 1 mM EGTA, then assayed for O~ generation in the 
usual  buffer (with  Ca  ++  and  Mg++), released  64.1  ___  0.5  nmol  O~  for  LPS- 
pretreated cells and 39.7 _+ 3.5 nmol for control (60 min pretreatment with 10 
ng/ml LPS; n  =  2,  PMA as  stimulus).  All of the experiments described were 
performed without serum present. However, the effect could be demonstrated 
in the presence of 10% normal human serum (32.5 -  4.2 nmol for LPS-treated 
cells compared with  22.9  -+  4.7  nmol  for control cells;  n  --  3,  fixed immune 
complexes as stimulus). 
Effect  of LPS  on  binding  of FMLP  to  neutrophils.  To  explore  further  the 
molecular basis  for the enhanced oxidative response of LPS-pretreated cells  to 
FMLP, the binding of radiolabeled FMLP was compared in buffer- and LPS- 
pretreated cells.  As summarized in  Table  IV,  the average number of binding 
sites per cell was slightly, but significantly, decreased in LPS-pretreated cells, and 
the  binding  affinity was  equivalent.  Thus,  the  enhanced  response  of  LPS- 
pretreated cells could not be ascribed to the increased binding of the stimulus, 
at least with FMLP as stimulus. 
NADPH-dependent production  of 02  by  neutrophil  particulate fractions.  The 
enzyme system believed to be  responsible for the initiation of the respiratory 
burst has been isolated in a  membrane-rich subcellular fraction prepared from 
intact  neutrophils  stimulated with  PMA  or  opsonized  zymosan (14-16).  We 1664  PRIMING  OF  NEUTROPHILS  BY  LIPOPOLYSACCHARIDE 
TABLE  IV 
Effect of Preincubation of Neutrophils with LPS on the Binding of 
Radiolabeled FMLP* 
Binding of 3H-FMLP* 
Neutrophils preincubated with: 
Buffer  LPS 
No. of binding sites/cell  43,200 _+ 3,200  29,600 _  4,400 
Affinity (Kd, nM)  14.0 +-- 1.2  10.1  -+ 3.8 
* Cells were preincubated for 60 min with buffer (KRPD) or with KRPD 
containing LPS,  10 ng/ml, then incubated with F-met-leu-3H phe and 
processed for cell-associated radioactivity (Materials and Methods). 
~: Mean __. SEM, n  =  4. The number of binding sites on LPS-pretreated 
cells was significantly decreased (P <  0.05, paired t test). The values for 
Kd are not significantly different. 
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FIGURE 3.  Generation of O~ by particulate fractions made from neutrophils preincubated 
with LPS,  10 ng/ml for 60 min, or with buffer alone (control), then stimulated with PMA. 
The rate of O~ release is plotted as a function of the concentration of NADPH in the reaction 
mixture. Means _  SEM of two experiments are plotted. A third experiment done at different 
concentrations of NADPH gave almost identical values for the calculated Kin, and the value 
for V~x was three times higher in the fraction from LPS-treated cells. In collated data the V,,.~ 
was significantly increased with fractions from LPS-treated cells (P <  0.001, n =  2; P <  0.02, 
n =  3; paired t tests), using values obtained from analysis of Lineweaver-Burk double reciprocal 
plots and  from  a  nonlinear regression  fit of the  data  to  the  hyperbolic  Michaelis-Menten 
equation (17). 
explored  the possibility that  the capacity of LPS pretreatment  to enhance  the 
stimulated release of 02 might be achieved through an increase in the efficiency 
or cellular  content  of this  enzyme.  In  these experiments,  enzyme activity was 
studied  as  NADPH-dependent  production  of 02.  Particulate  fractions  were 
prepared  from  LPS-treated  and  control  cells  stimulated  with  PMA,  or  from 
resting cells. As shown  in  Fig.  3,  the  subceilular fraction  prepared  from  LPS- 
treated  neutrophils  demonstrated  enhanced  NADPH-dependent  release of 02 GUTHRIE ET  AL.  1665 
over a  wide range of NADPH  concentrations.  Using analysis of Lineweaver- 
Burk plots, the calculated Km was the same for fractions from both LPS-treated 
and buffer-treated neutrophils (45 +  7 #M and 44 __. 5 #M, respectively; mean 
+  SEM,  n  ---  3).  However, the  Vmax was  increased 2.5-fold  in  the particulate 
fractions from LPS-treated cells (165  _+ 36 nmol/min per mg for LPS-treated 
fractions and 65  _  6  nmol/min per mg for controls;  n  --  3).  The particulate 
fractions from resting  (unstimulated) LPS-pretreated and control neutrophils 
showed minimal O~-producing activity (0.6 and 0.4 nmol/min per mg, respec- 
tively; means, n  --- 3). Thus, preincubation with LPS was not sufficient in itself 
to activate the OF-producing enzyme. 
Discussion 
The data reported here indicate that human blood neutrophils can be primed 
by exposure to low concentrations of LPS so that they release increased amounts 
of O~ when stimulated.  Optimal  priming of neutrophils was achieved during 
-60 min of incubation with LPS; incubation for >120  min resulted in a slight 
decline in  O~ release (data  not  shown).  Mononuclear phagocytes can also be 
primed with LPS, but optimal priming required incubation for 24 h for macro- 
phages and  48  h  for monocytes (4,  5).  A  pronounced  modification like  that 
shown in O~ release might have been predicted for mononuclear phagocytes, in 
view of their known capacity to change size, shape, enzyme content and activity, 
microbicidai and cytolytic activities, and other characteristics, both in the body 
and in culture (1). However, the increases in the respiratory burst and in activity 
of NADPH oxidase in subcellular fractions (Fig. 3) that were induced by exposure 
of neugrophils to  LPS were also pronounced and indicate that the circulating 
neutrophil is not the metabolically immutable, end-stage cell that  it has been 
generally conceived to be. 
In this regard our findings support the conclusions of Granelli-Piperno et al. 
(2, 3), who found that human neutrophils actively synthesize protein, RNA, and 
plasminogen activator in vitro. The priming effect achieved by LPS apparently 
did not require protein synthesis; but it could not be achieved at 0°C and was 
reduced at room temperature compared with 37°C (data not shown), which is 
compatible with a requirement for enzymatic activity. Prior exposure to chemo- 
tactic factors (C5 fragments, FMLP) also has been shown to enhance neutrophil 
oxidative metabolic  responses and  bactericidal activity (reviewed in  reference 
18), as well as O~ production by particulate fractions from stimulated cells (18, 
19).  It is not clear whether the mechanism of enhancement of the respiratory 
burst is the same with LPS and chemotactic factors, but the differing require- 
ments for achieving enhancement with the two stimuli suggest that the mecha- 
nisms may differ. Optimal priming with FMLP could be achieved in  15 s to 2 
min, with subsequent loss of the effect by as early as I0 min; and enhancement 
was much reduced if the chemotactic factors were removed before addition of 
the stimulus (18-20; Guthrie and Johnston, unpublished observations). Also, we 
have found that  cytochalasin B,  5  #g/ml,  added  5  min  before beginning the 
preincubation with  LPS,  had no effect on  LPS-induced priming,  measured as 
rate of OF release from FMLP-stimulated cells (6.1- and 6.3-fold increases with 1666  PRIMING  OF  NEUTROPHILS  BY  LIPOPOLYSACCHARIDE 
and without cytochalasin B, respectively; means, n  =  2), whereas cytochalasin B 
significantly enhanced priming induced by chemotactic factors (18, 19). 
LPS in our experiments did not appear to act as a stimulus, either by itself or 
in combination with another, primary stimulus. LPS alone did not cause release 
of O~,  even when added in  concentrations  up to  100-times  higher  than  those 
used  by us  routinely  (data  not  shown).  The  presence  of LPS  in  the  reaction 
mixture with a stimulus did not increase the extent of O~ release induced by that 
stimulus. Preincubation of cells and LPS at 37 °C for at least 30 rain was required 
to  achieve  a  significant  enhancement  of stimulated  OF release,  whether  the 
stimulus was FMLP, PMA, or fixed immune complexes. The possibility that LPS 
might have a direct serum-independent stimulatory effect on neutrophil oxidative 
metabolism  has been  investigated previously.  Apparently contradictory  results 
have been reported,  even from the same laboratory.  Higher concentrations  of 
LPS (5-500 #g/ml) than  used in our experiments (10 ng/ml) have been shown 
to directly stimulate hexose monophosphate shunt activity (21-23) and reduction 
of  nitroblue  tetrazolium  (22-24),  but  neither  of these  events  is  necessarily 
dependent on the respiratory burst. On the other hand,  these concentrations of 
LPS did not directly stimulate neutrophil  generation  of O~ (22, 23, 25, 26) or 
chemiluminescence  (23),  or  NADPH oxidizing  activity in  particulate  fractions 
(22).  Results with oxygen consumption have been conflicting (21,  23).  Lipid A 
(5  #g/ml)  added  to  neutrophils  settling  onto  petri  dishes  has  been  shown  to 
increase their adherence and concurrent release of OF (25, 26). This effect did 
not require a  preincubation  period, but there was an absolute requirement  for 
attachment  of the cells to a  surface.  In  experiments  probably related  to those 
shown here,  preincubation  of LPS with rabbit  (27) or guinea  pig (28) elicited 
peritoneal neutrophils has been shown to enhance phagocytic bactericidal activity 
(27) or stimulated release of O~ (28). 
Studies of the effect of LPS on oxidative metabolism with  serum or plasma 
present in the reaction mixture also have given contradictory results (22, 23, 25, 
27,  29).  At least some of the contradiction  might  be due to LPS activation  of 
complement in some systems, with generation of byproducts, especially C5a and 
C5adesArg, that  are  capable of stimulating  oxidative  metabolism  (30,  31).  This 
stimulatory effect could be modified by the binding and inactivation of the LPS 
by proteins present  in  serum (32).  Although  the priming  effect of LPS in our 
system could be achieved with serum in the incubation mixture, the data reported 
here were obtained in the absence of serum in order to permit study of the direct 
interaction  between LPS and neutrophils.  Priming was achieved in our experi- 
ments using concentrations  of LPS similar to those detectable by limulus assay 
in the blood of patients with gram-negative bacteremia (0.5-5 ng/ml) (33). 
Inattention to the content of LPS in buffers and reagents used to isolate cells, 
or in  the assays themselves,  might  also explain  some of the  discordant  results 
from different laboratories, or even in different assays within the same labora- 
tory.  We have found that  some lots of commercially available culture medium 
contain  LPS (by limulus assay) in  concentrations  of 10 ng/ml  to  1 /~g/ml;  that 
deionized water, commercial animal sera or albumin, and Ficoll solutions usually 
contain  LPS; and  that  salts used to prepare  buffers can become contaminated 
with LPS once opened. In addition, buffers can leach LPS from micropore filters GUTHRIE ET AL.  1667 
(5). In the least, it would seem important to determine the concentration of  LPS 
in all materials used to study the effect of LPS on neutrophils and, in fact, in any 
materials  incubated  with  neutrophils  in  assays  of their  biologic  activity.  The 
agents used to elicit cells into the peritoneal cavity of animals, through contami- 
nating LPS or their own stimulatory capacity, also might modify the effects of 
later exposure of the cells to LPS. 
The molecular basis for the priming effect of LPS on neutrophils might involve 
any of several possible modifications of the cell, none of them mutually exclusive: 
(a) the plasma membrane might be altered so that contact with or binding of the 
stimuli might be greater; (b) the events that couple receptor-stimulus interaction 
to stimulation of the enzyme responsible for OF production (the oxidase) might 
be altered, such that more enzyme is activated; or (c) the conformation of the 
enzyme or  its  placement  in  the  membrane  might  be  changed,  such  that  it 
expresses higher activity. Our  studies suggest that  increased binding  is  not a 
relevant mechanism, at  least with  FMLP.  Our  studies of NADPH-dependent 
generation of OF by particulate fractions indicate that the Km of the oxidase for 
NADPH has not been changed, suggesting that, if modifications of the enzyme 
or its environment have occurred, they have not influenced interaction of the 
oxidase with its substrate. However, the Vmax of the oxidase was increased about 
2.5-fold by LPS priming. Since cycioheximide did not inhibit LPS priming, the 
increased Vmax is more likely due to more efficient activation of the oxidase than 
to synthesis of additional enzyme. These results differ from those obtained in 
studies of the oxidase in normal and activated mouse macrophages: the enzyme 
from activated macrophages had a decreased apparent Km for NADPH and slight 
or no increase in Vmax (34, 35). 
Modifications in stimulus-response coupling (transduction) could be responsi- 
ble, at least in part,  for the enhanced activity of NADPH oxidase induced by 
LPS.  It has been reported that LPS is metabolized by human neutrophils and 
that in this process the lipid A  moiety undergoes deacylation to yield free fatty 
acids (36).  Free unsaturated fatty acids can induce OF release from neutrophils 
(reviewed in reference 37) and directly activate the neutrophil Ca  ++- and phos- 
pholipid-dependent protein kinase (protein kinase C) (37). This enzyme appears 
to  play a  role  in  signal  transduction  in  a  variety of cells (38),  and it  may be 
involved in stimulation of the respiratory burst in human neutrophils (37).  The 
time and temperature requirements for LPS priming (30-120  min, optimal at 
37°C) are consistent with formation of an LPS metabolite that might stimulate 
protein  kinase  C  or  with  stimulation  of phosphatidylinositol  turnover  in  the 
plasma membrane, which could stimulate protein kinase C  or, perhaps,  prime 
the cell in some other manner (38). LPS-induced priming could serve as a useful 
model for the study of signal transduction in neutrophils. 
The priming effect of LPS on neutrophils was apparent using three different 
assay procedures for measuring oxidative metabolism,  i.e.,  OF release,  HzO2 
release, and oxygen consumption.  However, the amount of enhancement was 
lower when oxygen consumption, rather than OF or H~O~ release, was measured. 
Since the assay for oxygen consumption detects only net oxygen uptake, it  is 
possible that one or more of the intracellular reactions that regenerate oxygen 1668  PRIMING  OF  NEUTROPHILS  BY  LIPOPOLYSACCHARtDE 
(e.g., dismutation of OF to H20~ and oxygen and breakdown of H,O2 by catalase) 
is increased by exposure of the cell to LPS. 
The findings reported here could have clinical relevance. A possible relation- 
ship could exist to the neutrophil-mediated inflammatory tissue damage believed 
to occur in endotoxemic states. One such state might be the adult respiratory 
distress syndrome associated with infection (39, 40).  Experimental models for 
this syndrome indicate a requirement for neutrophils for the damage to alveolar 
capillary endothelium and pulmonary interstitium that characterizes the condi- 
tion (41,  42).  The pathogenesis of the syndrome, as currently conceptualized 
(39), begins with C5a-induced adhesion of neutrophils to lung vascular endothe- 
lium. The adherent neutrophils release constituents, including proteases, which 
can destroy structural proteins, and toxic oxygen metabolites, which can damage 
endothelial  cells  (43)  and  inactivate  alveolar  proteinase  inhibitor  (44).  The 
priming effect of LPS shown here could accentuate the destructive capabilities 
of neutrophils in such a system. Similar considerations might apply to endotoxic 
shock, in which neutrophiis are believed to play an essential role in tissue damage 
(45). 
Summary 
We investigated the capacity of bacterial endotoxin (lipopolysaccharide, LPS) 
to modify the oxidative metabolic response to membrane stimulation of human 
neutrophils. Neutrophils were pretreated for 60 min with LPS, 10 ng/ml, then 
stimulated by exposure to  fixed immune complexes, the chemotactic peptide 
formyl-methionyl-leucyl-phenylalanine (FMLP),  or  phorbol  myristate  acetate. 
Release of superoxide anion (OD was up to 7-times greater in cells preincubated 
with LPS, depending upon the stimulus used. Consumption of  oxygen and release 
of hydrogen peroxide (H~O2) were similarly increased, using FMLP as stimulus. 
The enhancement was accompanied by a reduction in lag time and an increase 
in the rate of the response, but the duration of the oxidative events was  not 
changed. 
The molecular basis for the augmented oxidative response of LPS-pretreated 
cells was investigated. Preincubation with LPS at 0°C prevented priming, but 
preincubation in  the presence of cycloheximide or chelation of extracellular 
calcium ion did not. Neutrophils preincubated with LPS had slightly decreased 
numbers of binding sites and equivalent binding affinity for radiolabeled FMLP. 
Possible changes in the enzyme responsible for the oxidative burst were analyzed 
by studying NADPH-dependent generation of O~ by particulate fractions from 
cells preincubated with LPS or buffer, then stimulated before cell disruption. 
The fraction prepared from LPS-pretreated neutrophils exhibited greater release 
of OF over a wide range of concentrations of NADPH. The calculated apparent 
Km for NADPH was equivalent in the two fractions, but the Vn~x was increased 
2.5-fold in the subcellular fraction from LPS-pretreated cells. 
These results suggest that LPS could increase neutrophil-mediated host de- 
fense  or  the  tissue  damage  associated  with  endotoxemia by  enhancing  the 
generation of oxygen metabolites by neutrophils. These results also support the 
concept that the neutrophil is not an end-stage cell in regard to function or 
metabolic activity. GUTHRIE ET AL.  1669 
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